glp-1 obesity drug news today september 15 2025 Alarming rise in weight loss overdoses Nutritional priorities to support GLP-1
Description
Ledo JH, Azevedo EP, Clarke JR, Ribeiro FC, Figueiredo CP, Foguel D, et al
However, data on the glycaemic benefits of perioperative GLP-1 RAs suggest that restarting these medications in the postoperative setting might be desirable in a select cohort of patients who are able to resume their usual diets, and do not have gastrointestinal symptoms
At the time of the study in early 2024, about 0.5% of the adult population in the US was using GLP - 1 therapies
Combatting Sarcopenia: Strength training is critical in overcoming the age-related loss of muscle mass
